- Ms Serena Ekman
- Ms Sandra Sowah
- Ms Dinora Roche Recinos
- Ms Nadya Panagides
- Mr Michael MacDonald
- Ms Ruby Pelingon
- Ms Eunike (Nysa) McGowan
- Ms Katelyn Richards
- Ms Kristina Pleitt
- Mr Sathish Nadar
- Mr Matthias Nöbel
- Ms Veronica Yeo
- Mr Aiden Beauglehole
- Mr Filip Radenkovic
- Mr William Bramley
Ms Serena Ekman
RHD STUDENT - AUSTRLALIAN RED CROSS BLOOD SERVICE PROJECTS
PROJECT: Isolation of novel typing antibodies that bind hybrid glycophorin on red blood cellsSerena Ekman is a PhD student, who is currently undertaking her studies in a collaborative effort between the Brisbane Australian Red Cross Blood Service precinct and the ARC Training Centre in Biopharmaceutical Innovation at the AIBN for her project Isolation of novel typing antibodies that bind hybrid glycophorin on red blood cells. Serena has recently completed her degree in Advanced Science from the University of New South Wales majoring in Biotechnology and Microbiology, as well achieving a first class honors at the Garvan Medical Research Institute. She has also participated in a variety of science communication and volunteering events such as the Australian Museum Science Festival, presenting a biotechnology startup for the Peter Farrell Cup Pitching Competition, and volunteering with the Young Scientists of Australia.
QualificationsBSc Advanced Science (Biotechnology/Microbiology), University of New South Wales.
Ms Sandra Sowah
RHD STUDENT - AUSTRALIAN RED CROSS BLOOD SERVICE PROJECTS
PROJECT: Identifying novel red blood cell targets as a basis for development of biopharmaceuticals for treatment of infectious diseasesSandra A. Sowah is a trained biochemist with research and teaching experience. She obtained her degree in biochemistry from the University of Ghana where she completed her Bachelor of Science and Master of Philosophy trainings respectively. She has also completed a short internship program at the Novartis Institute for Biomedical Research in 2014, as part of their Next Generation Scientists program. There she worked mainly on establishing a degranulation assay. For her master’s level dissertation, she evaluated the diagnostic accuracy of QuantiFERON-TB Gold In-Tube assay for detection of tuberculosis in contacts of TB patients. She has also worked on several projects in different fields, with particular focus on laboratory diagnosis of infectious diseases. Notably, she has profiled host immunological responses to recently discovered, differentially expressed Mycobacterium tuberculosis proteins from exposure to Mycobacterium tuberculosis to active TB disease in a case-contact study in Ghana. Sandra’s research interests are:
- Laboratory diagnosis of infectious diseases
- Immunology of infectious diseases
- Vaccine development
QualificationsBSc and MPhil in Biochemistry, University of Ghana.
Ms Dinora Roche Recinos
RHD STUDENT - CSL CHARACTERISATION PROJECT
PROJECT: Comparability studies of biopharmaceuticals produced by fed-batch or perfusion cultureDinora Roche Recinos graduated with honors as a Biochemist and microbiologist from Universidad del Valle de Guatemala. Later on, she obtained an Australian Award Scholarship (AUSAid), to pursue her masters degree in Biotechnology at the University of Queensland. For her thesis work, at the Australian Institute of Bioengeneering and Nanotechnology (AIBN), she worked on Production and characterization of protein scaffolds specifically presenting peptides that target VEGFR-2 and EGFR for Triple Negative Breast Cancer (TNBC). She was also awarded with the Summer School Scholarship at the Universidad Complutense in Madrid, Spain, for a genomics fellowship. She is currently working as an university lecturer and associate researcher as well as Technical coordinator of the Plant Protection Laboratory of the Center for Agricultural and Food Technology Studies at the Research Institute of Universidad del Valle de Guatemala.
QualificationsBSc in Biochemistry/Microbiology, Universidad del Valle de Guatemala. M.Sc in Biotechnology, University of Queensland
Ms Nadya Panagides
RHD STUDENT - CSL DISCOVERY PROJECT
PROJECT: Isolation and characterisation of novel antibodies against cell-surface biomarkersNadya Panagides obtained her undergraduate degree in Biomedical Sciences with a sub-major in Genetics from the University of Queensland. She successfully completed two summer semester research projects and her honours degree in the Venom Evolution Laboratory, working with Dr Bryan Fry. Her venoms based research involved proteomically characterising a variety of African viper and cobra venoms, and for her honours thesis in particular, assessing their toxicological activity and potential as anti-cancer agents. She continued her work with venom toxins by volunteering at the QIMR Berghofer Medical Research Institute, by working in Dr John Miles’ Human Immunity Laboratory under the supervision of Dr Maria Ikonomopoulou. She began to develop a keen interest in immunology and started working as a Research Assistant in Dr Barbara Rolfe's laboratory at the AIBN, where her research focus shifted to cancer immunology, and more specifically the role of complement components C3a and C5a in tumour progression. Recently, Nadya was awarded the ARC Training Centre in Biopharmaceutical Innovation PhD scholarship. Her project will involve developing platform methodologies for antibody discovery against membrane proteins.
QualificationsBSc in Biomedical Sciences (Genetics), University of Queensland.
Mr Michael MacDonald
RHD STUDENT - PATHEON UPSTREAM BIOPROCESSING PROJECTS
PROJECT: Cell line development for high cell density cultureMichael MacDonald is a Biological Engineer pursuing a career in pharma R&D. He graduated from the University of Queensland in 2014 with a master's degree in Chemical and Biological Engineering with honours. As an undergraduate researcher, Michael has worked in human stem cell culture and microbioreactor design, and has been published for work on immunoglobulin profiling and assay development for saliva-based matrices. Michael has transferred from the downstream process department Patheon Biologics Brisbane to pursue a PhD centred on cell line development for the Patheon XD proces.
QualificationsMasters Degree with Honours in Chemical and Biological Engineering, University of Queensland
Ms Ruby Pelingon
RHD STUDENT - CSL CHARACTERISATION PROJECTS
PROJECT: Engineering and production of recombinant proteins with appropriate glycostructures for early in vivo studiesRuby Pelingon will be joining Dr. Benjamin Schulz team at Australian Institute for Bioengineering and Nanotechnology around mid this year (2017) to study PhD titled “Engineering and production of recombinant proteins with appropriate glycostructures for early in vivo studies”. Currently, she is still working at Institute for Molecular Bioscience, with the Cooper group, as a research assistant undertaking ADME/PK studies for the NLRP3 inhibitor project. Prior to this, Ruby worked at Interphil Laboratories responsible for analytical method development and validation. She received her Bachelor of Science in Chemistry degree from Silliman University.
QualificationsBSc in Chemistry, Silliman University
Ms Eunike (Nysa) McGowan
RHD STUDENT - APA SCHOLARSHIP ON AUSTRALIAN RED CROSS BLOOD SERVICE PROJECTS
PROJECT: An in vitro investigation of human antibodies to blood group antigens: Application for improved patient and blood donor managementNysa’s Honours project on developing an assay to quantify sheep inflammatory cytokines was a collaboration between the Critical Care Research Group at the Prince Charles Hospital and Australian Red Cross Blood Service. Nysa’s Honours project also received a New Investigator grant from The Prince Charles Hospital Foundation. This assay would help characterise the inflammatory response in an animal model of extracorporeal membrane oxygenation (ECMO) receiving transfusion with either fresh or old blood. Upon completion of Nysa’s Honours, Nysa was then employed by the Australian Red Cross Blood Service as a Research Assistant. For just over three years in this position, she gained knowledge and laboratory skills in resolving the complexities of blood typing the RhD antigen when there is a gene variant. As a PhD student, Nysa will be continuing to explore the realm of blood typing with the Australian Red Cross Blood Service and ARC Training Centre for Biopharmaceutical Innovation at the Australian Institute of Bioengineering and Nanotechnology.
QualificationsBachelor of Applied Science (Medical Science) and Bachelor of Biomedical Science (Honours), Queensland University of Technology.
Ms Katelyn Richards
RHD STUDENT - APA SCHOLARSHIP ON AUSTRALIAN RED CROSS BLOOD SERVICE PROJECTS
PROJECT: An analysis of systems that modify red blood cell (RBC) antigens and their role in RBC maturation, lifespan and disease resistance.Katelyn graduated from UQ with a BE/BSc in 2013, where she majored in Chemical and Biological Engineering and Genetics. She completed her BSc(hons) with a specialisation in Biochemistry in 2014 and developed thermostable Cytochrome P450 enzymes for drug development. Her research interests include, broadly, protein biochemistry, enzymology and recombinant expression systems. She recently started her PhD in partnership with the Australian Red Cross Blood Service where her research focuses on carbohydrate modification systems in mice and how these systems impact red blood cell surface antigens and their role in disease resistance. In her spare time, Katelyn enjoys sewing, millinery, fashion design and regularly competes in Fashions on the Field events.
QualificationsBE/BSc in Chemical and Biological Engineering and Genetics, University of Queensland.
Ms Kristina Pleitt
RHD STUDENT - PATHEON/GE DOWNSTREAM BIOPROCESSING PROJECT
PROJECT: From traditional to integrated continuous downstream bioprocess for valuable productsKristina Pleitt is currently employed in the downstream Process Development (PD) group at Patheon, a part of Thermo Fisher Scientific, in St. Louis, MO USA. She’s worked in the downstream PD group for 6 yrs developing and scaling biological purification processes for monoclonal antibodies and recombinant proteins. Her educational background is in Chemical Engineering (degree from Missouri University of Science and Technology). Kristina is an AIBN PhD student working on developing efficient continuous chromatography processes for the biopharmaceutical industry.
Mr Sathish Nadar
RHD STUDENT: PATHEON/GE DOWNSTREAM BIOPROCESSING PROJECT
PROJECT: Membrane-based separations for biopharmaceutical purificationSathish was part of the Downstream process development team at Pfizer Biologics Development Centre, Chennai (India) specialized in purification of monoclonal antibodies. Prior to joining Pfizer, he was employed as Associate Engineer for 2 years in Downstream Process Team at Intas Pharmaceuticals, Ahmedabad (India), where he worked on late stage process development for Bio-similar molecules. His stint of 4 years in Bio-pharma industry helped him in identifying the research area of his interest and the career path he would like to take. Sathish strongly believes that this opportunity at CBI, while help him gain in-depth understanding and broaden his expertise in working with bio-pharmaceuticals. His Educational background is in Bio-process technology (Post graduate degree from Institute of Chemical technology, India). He has completed his Bachelor of Engineering degree in Biotechnology from North Maharastra University, India.
Mr Matthias Nöbel
RHD STUDENT - PATHEON UPSTREAM BIOPROCESSING PROJECTS
PROJECT: Examining metabolic demands for continuous bioprocessing – in silico modellingQualifications: BSc in Molecular and Applied Biotechnology, RWTH Aachen. MSc in Biotechnology, Lund University Fascinated by the versatility of molecular processes and their applicability to human problems Matthias decided persue a Bachelors degree in Biotechnology at the RWTH Aachen, Germany in which he got introduced to a wide range of different aspects of biotechnology. Longing for more practical and international experience he completed a 6 month internship at the Fraunhofer Institute for Molecular Biotechnology located in the US. Thereby he was working on the development of a universal VLP construct expressed in Nicotiana benthamiana and with an intended application in vaccination. Hooked by the international experience he went to Sweden to continue his education with a Masters program in Biotechnology. The applied profile gave him multiple opportunities to improve his lab skills, peaking in a master thesis in which he focused on the bacterial conversion of lignin and underlying metabolic pathways. During his PhD he will examine the metabolic demand in high density CHO cell cultures. Matthias considers himself extremly lucky to work in an environment surrounded by great minds with diverse backgrounds. Something he will surely profit from, just like the close cooperation with an industry partner. Overall he is eager to apply all the knowledge he has gained so far in a very applied project and make the next step in his career.
Ms Veronica Yeo
RHD STUDENT: PATHEON UPSTREAM BIOPROCESSING PROJECTS
PROJECT:Examining metabolic demands for continuous bioprocessing – omics dataVeronica Yeo obtained her Bachelor’s Degree with Honours in Chemical Engineering at the National University of Singapore. She went on to pursue a Research Master’s degree under a scholarship offered by the Singapore’s defence R&D organisation, DSO National Laboratories. Her Masters research projects at the Netherlands Proteomics Centre, Utrecht University, focused on using mass spectrometry to analyze proteomes of red blood cells as well as probing structural behaviour of proteins. A lipidomics review on the identification and characterisation of pathogen-specific lipids by mass spectrometry was completed too. Upon her graduation, Veronica continued working at DSO National Laboratories; applying her knowledge in biomolecular mass spectrometry and proteomics to the verification of biotoxins and bacterial agents. She moved on to A*STAR Bioprocessing Technology Institute (BTI) in 2014, where she assisted the Downstream Processing Group to apply mass spectrometry workflows for identifying protein aggregates and impurities that undermine the efficient purification of monoclonal antibodies. In late 2015, Veronica joined Sciex, contributing to both its manufacturing engineering and R&D teams at the mass spectrometry facility in Singapore. Currently, Veronica is a PhD student at CBI undertaking her research to examine the metabolic demands for continuous bioprocessing – omics data. She is specifically interested and excited to embark on this new journey with CBI. It can provide her with applied research training in systems biology, metabolomics and in silico modelling for upstream processing of high density CHO cell cultures; above all, a valuable opportunity to work in CBI and partnering with Patheon.
Mr Aiden Beauglehole
RHD STUDENT: CSL CHARACTERISATION PROJECTS
PROJECT: Investigating differential expression of antibodies and coagulation factors at the level of cellular processingAiden graduated from the University of Melbourne where he completed a BSc majoring in Zoology. He went on to complete a Masters of Biotechnology at RMIT where he graduated with distinction. Whilst at RMIT, he performed cell line engineering on HEK cells employing CRISPR and utilised tmFRET to study conformational changes in GLIC to gather information on anesthetic mechanism of action on mammalian pLGICs. He has recently begun his PhD in collaboration with CSL where he will examine cellular processing for the differential expression of coagulation factors.
Mr Filip Radenkovic
RHD STUDENT: AUSTRLALIAN RED CROSS BLOOD SERVICE PROJECTS
PROJECT: Development of antibodies against human neutrophil antigensFilip undertook his undergraduate studies at Griffith University where he completed a Bachelor of Biomedical Science majoring in biochemistry. He went on to do his honours at the Menzies Institute at Griffith University Gold Coast campus within the Tony Perkins Group where he looked into the effect of selenium supplementation on endogenous antioxidant capacity in early gestation. Graduating in 2015, Filip remained on as a research assistant and continued his investigation into the effect of selective antioxidant capacity on mitochondrial oxidative stress working on several publications. Recently Filip has begun a PhD at CBI working in collaboration with the Australian Red Cross Blood Service (ARCBS) to work towards the development of monoclonal antibodies against Human Neutrophil Antigens (HNA) implicated in severe forms blood transfusion related disorders.
Mr William Bramley